These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effect of diltiazem and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible porcine skeletal muscle. Foster PS; Denborough MA Br J Anaesth; 1989 May; 62(5):566-72. PubMed ID: 2730830 [TBL] [Abstract][Full Text] [Related]
7. In vitro interaction between halothane and succinylcholine in human skeletal muscle: implications for malignant hyperthermia and masseter muscle rigidity. Fletcher JE; Rosenberg H Anesthesiology; 1985 Aug; 63(2):190-4. PubMed ID: 4025868 [TBL] [Abstract][Full Text] [Related]
8. In vitro muscle contractures induced by halothane and suxamethonium. II: Human skeletal muscle from normal and malignant hyperthermia susceptible patients. Fletcher JE; Rosenberg H Br J Anaesth; 1986 Dec; 58(12):1433-9. PubMed ID: 3790395 [TBL] [Abstract][Full Text] [Related]
9. The effect of oxytocin on porcine malignant hyperpyrexia susceptible skeletal muscle. Sim AT; White MD; Denborough MA Clin Exp Pharmacol Physiol; 1987 Jul; 14(7):605-10. PubMed ID: 3436105 [TBL] [Abstract][Full Text] [Related]
11. Calmodulin-antagonist drugs and porcine malignant hyperpyrexia. Collins SP; White MD; Denborough MA Clin Exp Pharmacol Physiol; 1988 Jun; 15(6):473-7. PubMed ID: 3271620 [TBL] [Abstract][Full Text] [Related]
12. Biochemical basis of malignant hyperpyrexia. Moulds RF; Denborough MA Br Med J; 1974 May; 2(5913):241-4. PubMed ID: 4827070 [TBL] [Abstract][Full Text] [Related]
13. Similar susceptibility to halothane, caffeine and ryanodine in vitro reflects pharmacogenetic variability of malignant hyperthermia. Ginz HF; Girard T; Censier K; Urwyler A Eur J Anaesthesiol; 2004 Feb; 21(2):151-7. PubMed ID: 14977348 [TBL] [Abstract][Full Text] [Related]
14. Diltiazem inhibits halothane-induced contractions in malignant hyperthermia-susceptible muscles in vitro. Ilias WK; Williams CH; Fulfer RT; Dozier SE Br J Anaesth; 1985 Oct; 57(10):994-6. PubMed ID: 4041327 [TBL] [Abstract][Full Text] [Related]
15. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle. Nelson TE; Bedell DM; Jones EW Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384 [TBL] [Abstract][Full Text] [Related]
16. Ultrasound Elastography for Rapid, Real-time Detection of Localized Muscular Reaction in Malignant Hyperthermia-susceptible Pigs. Johannsen S; Türkmeneli I; Isbary S; Roewer N; Schuster F Anesthesiology; 2018 Nov; 129(5):989-999. PubMed ID: 30204593 [TBL] [Abstract][Full Text] [Related]
17. Screening for malignant hyperthermia susceptibility. Anderson IL; Rawstron RE; Dunlop DJ N Z Med J; 1980 Jun; 91(661):417-9. PubMed ID: 6930029 [TBL] [Abstract][Full Text] [Related]
18. Screening for malignant hyperpyrexia. Nelson TE; Austin KL; Denborough MA Br J Anaesth; 1977 Feb; 49(2):169-72. PubMed ID: 836748 [TBL] [Abstract][Full Text] [Related]
19. Procaine in malignant hyperpyrexia. Moulds RF; Denborough MA Br Med J; 1972 Dec; 4(5839):526-8. PubMed ID: 4642792 [TBL] [Abstract][Full Text] [Related]
20. Caffeine and halothane contracture testing in swine using the recommendations of the North American Malignant Hyperthermia Group. Allen GC; Fletcher JE; Huggins FJ; Conti PA; Rosenberg H Anesthesiology; 1990 Jan; 72(1):71-6. PubMed ID: 2297135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]